Lord, Abbett & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-116,845
Closed -$14.3M 702
2020
Q2
$14.3M Sell
116,845
-7,410
-6% -$841K 0.05% 421
2020
Q1
$10.9M Buy
124,255
+3,731
+3% +$395K 0.05% 416
2019
Q4
$12.6M Sell
120,524
-284,305
-70% -$31.9M 0.04% 480
2019
Q3
$46.6M Sell
404,829
-182,761
-31% -$27.7M 0.16% 215
2019
Q2
$101M Buy
587,590
+8,758
+2% +$1.51M 0.33% 67
2019
Q1
$97.6M Buy
578,832
+45,509
+9% +$6.77M 0.32% 75
2018
Q4
$51.9M Sell
533,323
-100,161
-16% -$13.1M 0.19% 166
2018
Q3
$109M Sell
633,484
-137,722
-18% -$19.9M 0.3% 70
2018
Q2
$108M Buy
+771,206
New +$110M 0.31% 62
2016
Q4
Sell
-143,758
Closed -$19.1M 980
2016
Q3
$19.1M Buy
+143,758
New +$13.7M 0.06% 437
2014
Q3
Sell
-46,959
Closed -$5.04M 1058
2014
Q2
$5.04M Buy
46,959
+4,131
+10% +$287K 0.01% 798
2014
Q1
$2.54M Buy
+42,828
New +$2.55M 0.01% 901

Other funds holding GWPH

Lord, Abbett & Co's GWPH Position: Q3 2020 in Review

Lord, Abbett & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 116,845 shares — an estimated $14.3M sold.

Lord, Abbett & Co first reported a position in GWPH in Q1 2014 and held it in 12 quarters. The position peaked at $109M in Q3 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Lord, Abbett & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 116,845 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $14.3M.
  • Lord, Abbett & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 12 quarters.
  • Lord, Abbett & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $109M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Lord, Abbett & Co's 13F filing for Q3 2020, filed 12 Nov 2020.